Literature DB >> 16227431

Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration.

Lanbo Shi1, Charles D Sohaskey, Bavesh D Kana, Stephanie Dawes, Robert J North, Valerie Mizrahi, Maria L Gennaro.   

Abstract

Transcription profiling of genes encoding components of the respiratory chain and the ATP synthesizing apparatus of Mycobacterium tuberculosis was conducted in vivo in the infected mouse lung, and in vitro in bacterial cultures subjected to gradual oxygen depletion and to nitric oxide treatment. Transcript levels changed dramatically as infection progressed from bacterial exponential multiplication (acute infection) to cessation of bacterial growth (chronic infection) in response to host immunity. The proton-pumping type-I NADH dehydrogenase and the aa3-type cytochrome c oxidase were strongly down-regulated. Concurrently, the less energy-efficient cytochrome bd oxidase was transiently up-regulated. The nitrate transporter NarK2 was also up-regulated, indicative of increased nitrate respiration. The reduced efficiency of the respiratory chain was accompanied by decreased expression of ATP synthesis genes. Thus, adaptation of M. tuberculosis to host immunity involves three successive respiratory states leading to decreased energy production. Decreased bacterial counts in mice infected with a cydC mutant (defective in the cytochrome bd oxidase-associated transporter) at the transition to chronic infection provided initial evidence that the bd oxidase pathway is required for M. tuberculosis adaptation to host immunity. In vitro, NO treatment and hypoxia caused a switch from transcription of type I to type II NADH dehydrogenase. Moreover, cytochrome bd oxidase expression increased, but cytochrome c oxidase expression decreased slightly (nitric oxide) or not at all (hypoxia). These specific differences in respiratory metabolism during M. tuberculosis growth arrest in vitro and in vivo will guide manipulation of in vitro conditions to model bacterial adaptation to host immunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227431      PMCID: PMC1255738          DOI: 10.1073/pnas.0507850102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

Review 1.  Bacterial respiration: a flexible process for a changing environment.

Authors:  D J Richardson
Journal:  Microbiology       Date:  2000-03       Impact factor: 2.777

Review 2.  Immunology of tuberculosis.

Authors:  J L Flynn; J Chan
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 3.  Protein secretion by Gram-negative bacterial ABC exporters--a review.

Authors:  R Binet; S Létoffé; J M Ghigo; P Delepelaire; C Wandersman
Journal:  Gene       Date:  1997-06-11       Impact factor: 3.688

4.  The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action.

Authors:  Helena I M Boshoff; Timothy G Myers; Brent R Copp; Michael R McNeil; Michael A Wilson; Clifton E Barry
Journal:  J Biol Chem       Date:  2004-07-09       Impact factor: 5.157

5.  Characterization of a two-component system, devR-devS, of Mycobacterium tuberculosis.

Authors:  N Dasgupta; V Kapur; K K Singh; T K Das; S Sachdeva; K Jyothisri; J S Tyagi
Journal:  Tuber Lung Dis       Date:  2000

6.  Respiration metabolism reduces oxidative and acid stress to improve long-term survival of Lactococcus lactis.

Authors:  Lahcen Rezaïki; Bénédicte Cesselin; Yuji Yamamoto; Karin Vido; Evelien van West; Philippe Gaudu; Alexandra Gruss
Journal:  Mol Microbiol       Date:  2004-09       Impact factor: 3.501

7.  Membrane topology and mutational analysis of Escherichia coli CydDC, an ABC-type cysteine exporter required for cytochrome assembly.

Authors:  Hugo Cruz-Ramos; Gregory M Cook; Guanghui Wu; Michael W Cleeter; Robert K Poole
Journal:  Microbiology (Reading)       Date:  2004-10       Impact factor: 2.777

8.  Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy.

Authors:  M I Voskuil; K C Visconti; G K Schoolnik
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

9.  Cytochrome bd biosynthesis in Bacillus subtilis: characterization of the cydABCD operon.

Authors:  L Winstedt; K Yoshida; Y Fujita; C von Wachenfeldt
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

10.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

View more
  145 in total

Review 1.  The challenge of new drug discovery for tuberculosis.

Authors:  Anil Koul; Eric Arnoult; Nacer Lounis; Jerome Guillemont; Koen Andries
Journal:  Nature       Date:  2011-01-27       Impact factor: 49.962

2.  Heme-heme and heme-ligand interactions in the di-heme oxygen-reducing site of cytochrome bd from Escherichia coli revealed by nanosecond absorption spectroscopy.

Authors:  Fabrice Rappaport; Jie Zhang; Marten H Vos; Robert B Gennis; Vitaliy B Borisov
Journal:  Biochim Biophys Acta       Date:  2010-05-28

Review 3.  TMC207: the first compound of a new class of potent anti-tuberculosis drugs.

Authors:  Alberto Matteelli; Anna Cc Carvalho; Kelly E Dooley; Afranio Kritski
Journal:  Future Microbiol       Date:  2010-06       Impact factor: 3.165

4.  Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice.

Authors:  Neeraj Dhar; John D McKinney
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

5.  Diacyltransferase Activity and Chain Length Specificity of Mycobacterium tuberculosis PapA5 in the Synthesis of Alkyl β-Diol Lipids.

Authors:  Megan H Touchette; Gopal R Bommineni; Richard J Delle Bovi; John E Gadbery; Carrie D Nicora; Anil K Shukla; Jennifer E Kyle; Thomas O Metz; Dwight W Martin; Nicole S Sampson; W Todd Miller; Peter J Tonge; Jessica C Seeliger
Journal:  Biochemistry       Date:  2015-08-24       Impact factor: 3.162

6.  Bacterial interactions and the microevolution of cytochrome bd: implications for pathogenesis.

Authors:  Peter J McNamara; Richard A Proctor
Journal:  J Bacteriol       Date:  2006-12       Impact factor: 3.490

7.  Mycobacterial bacilli are metabolically active during chronic tuberculosis in murine lungs: insights from genome-wide transcriptional profiling.

Authors:  Adel M Talaat; Sarah K Ward; Chia-Wei Wu; Elizabeth Rondon; Christine Tavano; John P Bannantine; Rick Lyons; Stephen A Johnston
Journal:  J Bacteriol       Date:  2007-03-23       Impact factor: 3.490

8.  Mycobacterium tuberculosis ftsH expression in response to stress and viability.

Authors:  Manjot Kiran; Ashwini Chauhan; Renata Dziedzic; Erin Maloney; Samir Kumar Mukherji; Murty Madiraju; Malini Rajagopalan
Journal:  Tuberculosis (Edinb)       Date:  2009-12       Impact factor: 3.131

9.  In vitro model of mycobacterial growth arrest using nitric oxide with limited air.

Authors:  Syed Hussain; Muhammad Malik; Lanbo Shi; Maria Laura Gennaro; Karl Drlica
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

10.  Hypoxia-activated cytochrome bd expression in Mycobacterium smegmatis is cyclic AMP receptor protein dependent.

Authors:  Htin Lin Aung; Michael Berney; Gregory M Cook
Journal:  J Bacteriol       Date:  2014-06-16       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.